Raul D Santos Selected Research

Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)

3/2022	Pharmacological treatment with lipid-lowering agents after molecular identification of familial hypercholesterolemia: results from the Hipercol Brasil cohort.
1/2022	Screening for Familial Hypercholesterolemia in Small Towns: Experience from 11 Brazilian Towns in the Hipercolbrasil Program.
1/2022	Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)-Free Low-Density Lipoprotein Cholesterol.
1/2022	Association of dietary patterns and components with atherosclerosis risk biomarkers in familial hypercholesterolemia.
1/2022	Screening of ABCG5 and ABCG8 Genes for Sitosterolemia in a Familial Hypercholesterolemia Cascade Screening Program.
11/2021	Advancing Prediction of Pathogenicity of Familial Hypercholesterolemia LDL Receptor Commonest Variants With Machine Learning Models.
3/2021	Advances with lipid-lowering drugs for pediatric patients with familial hypercholesterolemia.
1/2021	Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. Reply.
1/2021	Familial hypercholesterolemia and cardiovascular disease in older individuals.
1/2021	LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raul D Santos Research Topics

Disease

57	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 08/2006
56	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 03/2022 - 07/2005
49	Atherosclerosis 05/2022 - 08/2006
26	Dyslipidemias (Dyslipidemia) 01/2022 - 02/2003
25	Inflammation (Inflammations) 06/2022 - 05/2007
25	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 04/2002
24	Hypertension (High Blood Pressure) 01/2022 - 06/2003
23	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2007
22	Coronary Disease (Coronary Heart Disease) 09/2019 - 01/2005
16	Obesity 07/2021 - 03/2006
13	Hypercholesterolemia 01/2022 - 01/2013
12	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 03/2010
11	Type 2 Diabetes Mellitus (MODY) 07/2022 - 05/2009
11	Homozygous Familial Hypercholesterolemia 01/2021 - 04/2008
10	Myocardial Infarction 10/2020 - 02/2004
9	Xanthomatosis (Xanthoma) 01/2017 - 02/2008
7	Insulin Resistance 01/2021 - 04/2005
6	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2014
6	Stroke (Strokes) 06/2020 - 05/2009
5	Hypertriglyceridemia 10/2021 - 03/2006
4	COVID-19 06/2022 - 01/2021
4	Injection Site Reaction 01/2019 - 03/2010
4	Myocardial Ischemia (Ischemic Heart Diseases) 01/2017 - 01/2007
3	Hyperthyroidism 05/2022 - 11/2020
3	Unstable Angina 01/2019 - 07/2016
3	Overweight 01/2018 - 07/2013
3	Hyperlipidemias (Hyperlipidemia) 01/2017 - 02/2003
3	Vascular Calcification 12/2008 - 05/2007
2	Body Weight (Weight, Body) 07/2022 - 01/2022
2	Hypothyroidism 05/2022 - 11/2020
2	Heart Failure 10/2021 - 05/2007
2	Costello Syndrome 09/2021 - 09/2018
2	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 09/2021 - 09/2018
2	Vascular Diseases (Vascular Disease) 03/2021 - 08/2016
2	Thyroid Diseases (Thyroid Disease) 01/2021 - 08/2020
2	Prediabetic State (Prediabetes) 01/2020 - 01/2018
2	Pancreatitis 09/2018 - 08/2014
2	Obstructive Sleep Apnea 01/2018 - 04/2017
2	Aortic Valve Disease 01/2018 - 09/2014
2	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2017 - 05/2015
2	Arcus Senilis 01/2017 - 02/2008
2	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2016 - 08/2012
2	Fatty Liver 11/2014 - 01/2014
2	Fibrosis (Cirrhosis) 11/2014 - 01/2014

Drug/Important Bio-Agent (IBA)

59	LipidsIBA 03/2022 - 03/2003
57	LDL CholesterolIBA 03/2022 - 04/2002
56	oxidized low density lipoproteinIBA 05/2022 - 04/2002
40	CholesterolIBA 01/2022 - 03/2003
34	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 05/2007
29	HDL CholesterolIBA 01/2022 - 02/2004
28	Triglycerides (Triacylglycerol)IBA 01/2022 - 02/2003
20	C-Reactive ProteinIBA 01/2022 - 09/2009
18	Lipoproteins (Lipoprotein)IBA 01/2022 - 02/2003
17	CalciumIBA 01/2020 - 01/2005
15	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2005
15	LDL Lipoproteins (beta Lipoproteins)IBA 09/2019 - 09/2007
11	Lipoprotein(a)IBA 07/2022 - 08/2012
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2008
9	LDL Receptors (LDL Receptor)IBA 11/2021 - 07/2005
9	Proprotein Convertase 9IBA 09/2021 - 08/2012
9	EmulsionsIBA 03/2014 - 04/2002
8	ChylomicronsIBA 09/2021 - 04/2002
8	ApolipoproteinsIBA 01/2021 - 04/2002
8	HDL LipoproteinsIBA 10/2020 - 04/2005
8	mipomersenIBA 11/2019 - 03/2010
7	PCSK9 InhibitorsIBA 09/2021 - 01/2016
7	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2020 - 02/2004
7	Uric Acid (Urate)IBA 12/2012 - 04/2005
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2008
5	Blood Glucose (Blood Sugar)IBA 01/2022 - 05/2006
5	Monoclonal AntibodiesIBA 10/2021 - 01/2016
5	BMS201038IBA 03/2021 - 08/2014
5	bococizumabIBA 07/2018 - 08/2016
5	Adenosine Triphosphate (ATP)IBA 01/2014 - 08/2008
4	evolocumabIBA 01/2021 - 01/2017
4	alirocumabIBA 09/2019 - 01/2016
3	EnzymesIBA 01/2021 - 10/2005
3	Antisense OligonucleotidesIBA 01/2021 - 09/2014
3	Apolipoproteins B (ApoB)IBA 01/2021 - 04/2002
3	Ezetimibe (Zetia)FDA Link 09/2019 - 03/2014
3	Simvastatin (Zocor)FDA LinkGeneric 03/2014 - 07/2005
2	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 10/2021 - 03/2021
2	ALN-PCSIBA 10/2021 - 01/2021
2	Amino Acids FDA Link 04/2021 - 08/2010
2	evinacumabIBA 03/2021 - 01/2021
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 04/2017
2	fibrin fragment D (D-dimer)IBA 01/2021 - 06/2013
2	Apolipoprotein B-100 (Apo B 100)IBA 01/2021 - 03/2015
2	Apolipoproteins AIBA 01/2021 - 02/2008
2	CER-001IBA 10/2020 - 03/2015
2	TransferasesIBA 08/2020 - 01/2016
2	Insulin (Novolin)FDA Link 01/2019 - 01/2019
2	Pharmaceutical PreparationsIBA 10/2018 - 10/2005
2	omega-Chloroacetophenone (Mace)IBA 10/2018 - 07/2016
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 09/2018 - 05/2009

Therapy/Procedure

33	Therapeutics 01/2022 - 06/2004
3	Secondary Prevention 01/2021 - 06/2004
3	Renal Dialysis (Hemodialysis) 09/2013 - 01/2008
2	Mediterranean Diet 01/2021 - 12/2019
2	Blood Component Removal (Apheresis) 01/2020 - 09/2014